From: Outpatient red blood cell transfusion payments among patients on chronic dialysis
Patients | |
---|---|
N = 3,283a | |
Age, mean years (SD) | 60.9 (15.0) |
Sex, n male (%) | 1,850 (56.4) |
Geographic region, n (%) | |
Northeast | 253 (7.7) |
North Central | 975 (29.7) |
South | 1,459 (44.4) |
West | 585 (17.8) |
Unknown | 11 (0.3) |
Payer, n (%) | |
Commercial | 1,941 (59.1) |
Medicare | 1,342 (40.9) |
Deyo Charlson comorbidity index, mean score (SD) | 4.32 (2.45) |
Comorbid conditions, n (%) | |
Hypertension | 3,084 (93.9) |
Diabetes | 1,662 (50.6) |
CHF | 1,167 (35.6) |
Acute bleeding | 748 (22.8) |
Surgery | 719 (21.9) |
Cancer | 680 (20.7) |
COPD | 460 (14.0) |
Hyperkalemia | 423 (12.9) |
Dialysis modality, n (%) | |
Hemodialysis | 1,997 (60.8) |
Peritoneal dialysis | 207 (6.3) |
Unknown | 1,095 (33.4) |
Transfusion episodes with ≥ 30 days follow-up, mean number (SD) | 2.15 (3.78) |
Length of follow-up, mean days (SD) | 494.76 (474.19) |